Ardent Health (ARDT) EBIT Margin (2023 - 2026)
Ardent Health's quarterly EBIT Margin came in at 5.65% in Q1 2026, down 188.0% year-on-year from 6.42% in Q1 2025, and up 50.99% quarter-over-quarter from 11.54% in Q4 2025.
Ardent Health has reported EBIT Margin for 4 years, with the latest figure at 5.65% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin fell 188.0% year-over-year to 5.65%; the trailing twelve-month figure through Mar 2026 stood at 8.06% (up 292.0% YoY), and the FY2025 full-year result was 12.59%, down 136.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 5.65%, up from 11.54% in the prior quarter.
- The five-year high for EBIT Margin was 22.35% in Q4 2023, with the low at 31.81% in Q4 2024.
- Average EBIT Margin over 4 years is 6.24%, with a median of 4.92% recorded in 2024.
- Year-over-year, EBIT Margin sank 5416 bps in 2024 and jumped 2028 bps in 2025.
- Tracing ARDT's EBIT Margin over 4 years: stood at 22.35% in 2023, then sank by 242 bps to 31.81% in 2024, then surged by 64 bps to 11.54% in 2025, then soared by 51 bps to 5.65% in 2026.
- The last three EBIT Margin figures came in at 5.65% (Q1 2026), 11.54% (Q4 2025), and 12.74% (Q3 2025), per Business Quant data.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.65% |
| Dec 31, 2025 | -11.54% |
| Sep 30, 2025 | -12.74% |
| Jun 30, 2025 | -2.53% |
| Mar 31, 2025 | -3.78% |
| Dec 31, 2024 | -31.81% |
| Sep 30, 2024 | -4.18% |
| Jun 30, 2024 | -2.25% |
| Mar 31, 2024 | -13.98% |
| Dec 31, 2023 | 22.35% |
| Sep 30, 2023 | -5.71% |
| Jun 30, 2023 | -3.00% |